Trending Stock News

Pfizer Com (PFE) Shareholder Winch Advisory Services Has Lowered Its Stake as Share Price Declined; Orix (IX) Holder Naples Global Advisors Has Increased Its Holding by $329,300

Pfizer Inc. (NYSE:PFE) Logo

Winch Advisory Services Llc decreased its stake in Pfizer Inc Com (PFE) by 58.14% based on its latest 2018Q1 regulatory filing with the SEC. Winch Advisory Services Llc sold 24,536 shares as the company’s stock declined 3.80% with the market. The institutional investor held 17,666 shares of the health care company at the end of 2018Q1, valued at $627,000, down from 42,202 at the end of the previous reported quarter. Winch Advisory Services Llc who had been investing in Pfizer Inc Com for a number of months, seems to be less bullish one the $213.31B market cap company. The stock increased 0.68% or $0.245 during the last trading session, reaching $36.465. About 10.33M shares traded. Pfizer Inc. (NYSE:PFE) has risen 10.95% since June 20, 2017 and is uptrending. It has underperformed by 1.62% the S&P500. Some Historical PFE News: 05/04/2018 – Pfizer Closes Below 50-Day Moving Average: Technicals; 07/05/2018 – FDA Grants Priority Review to Genentech’s Cancer Immunotherapy TECENTRIQ (Atezolizumab) for Initial Treatment of People With a Specific Type of Metastatic Lung Cancer; 07/05/2018 – JANSSEN PHARMA – FDA APPROVAL OF DARZALEX IN COMBINATION WITH BORTEZOMIB, MELPHALAN AND PREDNISONE MARKS ITS FIFTH INDICATION IN MULTIPLE MYELOMA; 04/04/2018 – PFIZER INC – EUROPEAN MEDICINES AGENCY HAS ALSO ACCEPTED MARKETING AUTHORIZATION APPLICATION FOR DACOMITINIB FOR SAME INDICATION; 29/03/2018 – PFIZER INC – PRELIMINARY SAFETY DATA SHOWED THAT TAFAMIDIS WAS GENERALLY WELL TOLERATED; 10/04/2018 – TUBEROUS SCLEROSIS ALLIANCE SALUTES FDA APPROVAL OF AFINITOR® DISPERZ (EVEROLIMUS) AS THE FIRST ADJUNCTIVE TREATMENT APPROVED IN US FOR PATIENTS AGED 2 YEARS AND OLDER WITH TUBEROUS SCLEROSIS COMPLEX…; 23/03/2018 – STAT Plus: Pharmalittle: Glaxo drops out of bidding for Pfizer consumer unit; Trump policy could hike prices for biosimilars; 23/03/2018 – GSK pulls out of $20 bln race for Pfizer consumer assets; 09/04/2018 – Pfizer Canada and MaRS Innovation Partner to Convert Great Science into Solutions to Benefit Canadians’ Health; 01/05/2018 – Pfizer 1Q Innovative Health Rev Up 6%

Naples Global Advisors Llc increased its stake in Orix Corporation (IX) by 20.76% based on its latest 2018Q1 regulatory filing with the SEC. Naples Global Advisors Llc bought 3,700 shares as the company’s stock declined 6.31% with the market. The institutional investor held 21,525 shares of the diversified financial services company at the end of 2018Q1, valued at $1.93 million, up from 17,825 at the end of the previous reported quarter. Naples Global Advisors Llc who had been investing in Orix Corporation for a number of months, seems to be bullish on the $20.94 billion market cap company. The stock increased 0.16% or $0.13 during the last trading session, reaching $81.08. About 95,429 shares traded or 182.25% up from the average. ORIX Corporation (NYSE:IX) has risen 7.73% since June 20, 2017 and is uptrending. It has underperformed by 4.84% the S&P500. Some Historical IX News: 19/04/2018 – TABLE-Orix Jreit 8954.T -6 MTH results; 09/05/2018 – ORIX USA Corporation Rebrands to Reflect ORIX Group’s Global Presence; 09/05/2018 – TABLE-Orix 8591.T -2017/18 group results (SEC); 04/05/2018 – GERMANY’S DZ BANK GETS MUTED BUYER INTEREST FOR TRANSPORTATION UNIT DVB; 16/04/2018 – Moody’s Upgrades Orix To A3; Outlook Stable; 09/05/2018 – ORIX 8591.T 2017/18 GROUP (SEC) OPERATING PROFIT 336.20 BLN YEN (+2.1 %); 09/05/2018 – TABLE-Orix 8591.T -2017/18 parent results; 09/05/2018 – Orix Corp FY Rev Y2.86T Vs Y2.68T; 11/05/2018 – TABLE-Ubiteq 6662.T – 9-MTH group results; 29/03/2018 – Lanka Business: Japan’s Orix sells Sri Lanka LOLC stake for Rs.12.8Bn

Investors sentiment decreased to 0.89 in Q1 2018. Its down 0.17, from 1.06 in 2017Q4. It is negative, as 70 investors sold PFE shares while 718 reduced holdings. 104 funds opened positions while 595 raised stakes. 4.01 billion shares or 1.39% less from 4.07 billion shares in 2017Q4 were reported. Citizens & Northern Corporation has 32,193 shares for 0.85% of their portfolio. Moreover, Neuberger Berman Gru Ltd Com has 0.65% invested in Pfizer Inc. (NYSE:PFE) for 16.06 million shares. Boston Mngmt, a Massachusetts-based fund reported 20,172 shares. Mckinley Carter Wealth Inc, a West Virginia-based fund reported 29,223 shares. Citadel Advisors Ltd reported 121,461 shares or 0% of all its holdings. Insight 2811 reported 1.19% of its portfolio in Pfizer Inc. (NYSE:PFE). Adage Cap Ptnrs Grp Incorporated Ltd Liability Company has 6.67 million shares. Diamond Hill Capital Management reported 1.73% in Pfizer Inc. (NYSE:PFE). Westchester Cap Inc stated it has 3.02% in Pfizer Inc. (NYSE:PFE). Bennicas Assocs holds 0.74% of its portfolio in Pfizer Inc. (NYSE:PFE) for 23,357 shares. Macroview Investment Mgmt Limited Liability Corp holds 248 shares or 0.03% of its portfolio. Sentry Invests holds 0.8% or 1.51M shares. Sei Invs invested 0.35% of its portfolio in Pfizer Inc. (NYSE:PFE). The New York-based Forte Cap Ltd Co Adv has invested 0.39% in Pfizer Inc. (NYSE:PFE). Lakeview Cap holds 0.84% of its portfolio in Pfizer Inc. (NYSE:PFE) for 30,934 shares.

Winch Advisory Services Llc, which manages about $228.69 million and $170.70 million US Long portfolio, upped its stake in Alphabet Inc Com Cl C by 293 shares to 4,813 shares, valued at $4.97M in 2018Q1, according to the filing. It also increased its holding in Spdr Series Trust Portfolio Tl Stk Etf (THRK) by 250,005 shares in the quarter, for a total of 256,844 shares, and has risen its stake in Select Sector Spdr Trust Sbi Materials Etf (XLB).

More important recent Pfizer Inc. (NYSE:PFE) news were published by: Fool.com which released: “Better Buy: Pfizer Inc. vs. Johnson & Johnson” on June 17, 2018, also Bizjournals.com published article titled: “In quest to leapfrog Pfizer, Peninsula vaccine company gets $85 million injection”, Fool.com published: “Forget Johnson & Johnson: Here Are 2 Better Dividend Stocks” on June 20, 2018. More interesting news about Pfizer Inc. (NYSE:PFE) was released by: Seekingalpha.com and their article: “Pfizer – Still A Hold For The Dividend” with publication date: June 08, 2018.

Since February 24, 2018, it had 0 insider purchases, and 13 selling transactions for $18.09 million activity. $353,677 worth of Pfizer Inc. (NYSE:PFE) was sold by LUND-JURGENSEN KIRSTEN on Saturday, February 24. OLSON LAURIE J sold $692,582 worth of stock or 19,000 shares. $1.84M worth of Pfizer Inc. (NYSE:PFE) was sold by LANKLER DOUGLAS M. Shares for $998,666 were sold by JOHNSON RADY A on Tuesday, March 13. CORNWELL W DON sold $64,679 worth of stock. On Tuesday, March 6 the insider HILL CHARLES H sold $1.52M.

Among 23 analysts covering Pfizer (NYSE:PFE), 10 have Buy rating, 1 Sell and 12 Hold. Therefore 43% are positive. Pfizer had 80 analyst reports since July 29, 2015 according to SRatingsIntel. The stock has “Overweight” rating by JP Morgan on Thursday, April 7. The rating was maintained by Argus Research with “Buy” on Wednesday, July 29. The firm has “Neutral” rating given on Wednesday, November 25 by Suntrust Robinson. The firm has “Hold” rating given on Wednesday, August 16 by Jefferies. Jefferies maintained the shares of PFE in report on Monday, February 26 with “Hold” rating. The firm earned “Overweight” rating on Tuesday, November 29 by Barclays Capital. On Wednesday, November 1 the stock rating was maintained by UBS with “Buy”. The company was upgraded on Wednesday, September 20 by Morgan Stanley. Leerink Swann maintained Pfizer Inc. (NYSE:PFE) rating on Monday, May 2. Leerink Swann has “Market Perform” rating and $34.70 target. Piper Jaffray maintained the shares of PFE in report on Friday, August 28 with “Overweight” rating.

Pfizer Inc. (NYSE:PFE) Institutional Positions Chart

Leave a Reply

Your email address will not be published. Required fields are marked *